Dr. Jameason Cameron
Research Coordinator
613-737-7600 x4103

Degrees and Certifications

  • PhD in Human Kinetics – University of Ottawa
  • M.S. Human Kinetics – University of Ottawa
  • Hons. B.Sc. HK– University of Ottawa


Jameason Cameron is a postdoctoral fellow with the HALO group, working under Dr. Gary Goldfield. Dr. Cameron attained his M.Sc. while at Montfort Hospital in the Behavioural and Metabolic Research Unit, and in 2013 completed his doctorate looking at the role of appetite-related hormones, food reward, and olfaction in predicting appetite and food intake in normal weight and obese adults. Currently he is coordinating a project titled “The Effects of Prenatal Smoking on Adiposity and Metabolism in Young Children”. Dr. Cameron has also attained a NOL from Health Canada to begin a clinical drug trial examining the off-label use of the ADHD medication methylphenidate and its role in appetite and weight loss. Dr. Cameron’s main interests are explored using randomized controlled trials, often in paradigms of energy depletion, with the intention of identifying how physiological and behavioural changes are inter-related in the context of fasting and weight loss. New topics of interest include how the microbiome and genetic markers of impulsivity may impact obesity.